Articles producció científica> Medicina i Cirurgia

An MMP-degraded and cross-linked fragment of type III collagen as a non-invasive biomarker of hepatic fibrosis resolution

  • Identification data

    Identifier: imarina:9258986
    Authors:
    Pehrsson MManon-Jensen TSun SVillesen IFCastañé HJoven JPatel KGoodman ZNielsen MJBay-Jensen ACLeeming DJMortensen JHKarsdal MA
    Abstract:
    Liver fibrosis results from a prolonged wound healing response to continued injury with excessive production of extracellular proteins. In patients with chronic liver disease, the monitoring of liver fibrosis dynamics is of high interest. While markers of fibrogenesis exist, markers of hepatic fibrosis resolution remain an unmet clinical need. Thus we sought to develop an assay quantifying a circulating proteolytic fragment of cross-linked type III collagen as a biomarker of fibrolysis, testing its utility in two clinical cohorts of liver fibrosis of distinct aetiology and regressing endotype.We used a monoclonal antibody targeting the C-telopeptide of type III collagen following C-proteinase cleavage to develop and validate a neo-epitope-specific enzyme-linked immunosorbent assay (CTX-III). A potential fibrosis resolution marker, CTX-III, was measured in two clinical cohorts of patients with obesity-associated non-alcoholic fatty liver disease undergoing bariatric surgery or hepatitis C virus infection from a clinical trial study evaluating the anti-fibrotic effect of farglitazar.CTX-III was robust and specific for the targeted neo-epitope with good reproducibility in EDTA plasma. We assessed type III collagen remodelling using a panel of biomarkers, including a type III collagen formation marker (PRO-C3), degradation (C3M), and CTX-III (fibrolysis). Net fibrolysis was increased in patients with non-alcoholic fatty liver disease following bariatric surgery (p<0.001). Moreover, net fibrolysis identified spontaneous fibrotic regressors from stable and progressors (p<0.05 and p<0.001) among hepatitis C virus infection patients.Circulating CTX-III as a marker of fibrolysis, indicating the biomarker's beneficial use in assessing hepatic fibrosis resolution.This article is p
  • Others:

    Author, as appears in the article.: Pehrsson M; Manon-Jensen T; Sun S; Villesen IF; Castañé H; Joven J; Patel K; Goodman Z; Nielsen MJ; Bay-Jensen AC; Leeming DJ; Mortensen JH; Karsdal MA
    Department: Medicina i Cirurgia
    URV's Author/s: Castañé Vilafranca, Helena / Joven Maried, Jorge
    Keywords: Non-invasive biomarkers Hepatic fibrosis Fibrosis resolution Fatty liver-disease Collagen cross-linking sampling variability progression pro-c3 non-invasive biomarkers hepatic fibrosis fibrosis resolution
    Abstract: Liver fibrosis results from a prolonged wound healing response to continued injury with excessive production of extracellular proteins. In patients with chronic liver disease, the monitoring of liver fibrosis dynamics is of high interest. While markers of fibrogenesis exist, markers of hepatic fibrosis resolution remain an unmet clinical need. Thus we sought to develop an assay quantifying a circulating proteolytic fragment of cross-linked type III collagen as a biomarker of fibrolysis, testing its utility in two clinical cohorts of liver fibrosis of distinct aetiology and regressing endotype.We used a monoclonal antibody targeting the C-telopeptide of type III collagen following C-proteinase cleavage to develop and validate a neo-epitope-specific enzyme-linked immunosorbent assay (CTX-III). A potential fibrosis resolution marker, CTX-III, was measured in two clinical cohorts of patients with obesity-associated non-alcoholic fatty liver disease undergoing bariatric surgery or hepatitis C virus infection from a clinical trial study evaluating the anti-fibrotic effect of farglitazar.CTX-III was robust and specific for the targeted neo-epitope with good reproducibility in EDTA plasma. We assessed type III collagen remodelling using a panel of biomarkers, including a type III collagen formation marker (PRO-C3), degradation (C3M), and CTX-III (fibrolysis). Net fibrolysis was increased in patients with non-alcoholic fatty liver disease following bariatric surgery (p<0.001). Moreover, net fibrolysis identified spontaneous fibrotic regressors from stable and progressors (p<0.05 and p<0.001) among hepatitis C virus infection patients.Circulating CTX-III as a marker of fibrolysis, indicating the biomarker's beneficial use in assessing hepatic fibrosis resolution.This article is protected by copyright. All rights reserved.
    Thematic Areas: Saúde coletiva Nutrição Medicina veterinaria Medicina iii Medicina ii Medicina i Interdisciplinar Hepatology General medicine Gastroenterology & hepatology Farmacia Engenharias iv Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciência de alimentos Biotecnología Astronomia / física
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    Author's mail: helena.castane@estudiants.urv.cat jorge.joven@urv.cat
    Author identifier: 0000-0003-2749-4541
    Record's date: 2024-09-07
    Papper version: info:eu-repo/semantics/publishedVersion
    Link to the original source: https://onlinelibrary.wiley.com/doi/10.1111/liv.15270
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Papper original source: Liver International. 42 (7): 1605-1617
    APA: Pehrsson M; Manon-Jensen T; Sun S; Villesen IF; Castañé H; Joven J; Patel K; Goodman Z; Nielsen MJ; Bay-Jensen AC; Leeming DJ; Mortensen JH; Karsdal M (2022). An MMP-degraded and cross-linked fragment of type III collagen as a non-invasive biomarker of hepatic fibrosis resolution. Liver International, 42(7), 1605-1617. DOI: 10.1111/liv.15270
    Article's DOI: 10.1111/liv.15270
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2022
    Publication Type: Journal Publications
  • Keywords:

    Gastroenterology & Hepatology,Hepatology
    Non-invasive biomarkers
    Hepatic fibrosis
    Fibrosis resolution
    Fatty liver-disease
    Collagen cross-linking
    sampling variability
    progression
    pro-c3
    non-invasive biomarkers
    hepatic fibrosis
    fibrosis resolution
    Saúde coletiva
    Nutrição
    Medicina veterinaria
    Medicina iii
    Medicina ii
    Medicina i
    Interdisciplinar
    Hepatology
    General medicine
    Gastroenterology & hepatology
    Farmacia
    Engenharias iv
    Ciências biológicas iii
    Ciências biológicas ii
    Ciências biológicas i
    Ciência de alimentos
    Biotecnología
    Astronomia / física
  • Documents:

  • Cerca a google

    Search to google scholar